Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
den Hoed, MarcelEijgelsheim, Mark
Esko, Tõnu
Brundel, Bianca J J M
Peal, David S
Evans, David M
Nolte, Ilja M
Segrè, Ayellet V
Holm, Hilma
Handsaker, Robert E
Westra, Harm-Jan
Johnson, Toby
Isaacs, Aaron
Yang, Jian
Lundby, Alicia
Zhao, Jing Hua
Kim, Young Jin
Go, Min Jin
Almgren, Peter
Bochud, Murielle
Boucher, Gabrielle
Cornelis, Marilyn C
Gudbjartsson, Daniel
Hadley, David
van der Harst, Pim
Hayward, Caroline
den Heijer, Martin
Igl, Wilmar
Jackson, Anne U
Kutalik, Zoltán
Luan, Jian'an
Kemp, John P
Kristiansson, Kati
Ladenvall, Claes
Lorentzon, Mattias
Montasser, May E
Njajou, Omer T
O'Reilly, Paul F
Padmanabhan, Sandosh
St Pourcain, Beate
Rankinen, Tuomo
Salo, Perttu
Tanaka, Toshiko
Timpson, Nicholas J
Vitart, Veronique
Waite, Lindsay
Wheeler, William
Zhang, Weihua
Draisma, Harmen H M
Feitosa, Mary F
Kerr, Kathleen F
Lind, Penelope A
Mihailov, Evelin
Onland-Moret, N Charlotte
Song, Ci
Weedon, Michael N
Xie, Weijia
Yengo, Loic
Absher, Devin
Albert, Christine M
Alonso, Alvaro
Arking, Dan E
de Bakker, Paul I W
Balkau, Beverley
Barlassina, Cristina
Benaglio, Paola
Bis, Joshua C
Bouatia-Naji, Nabila
Brage, Søren
Chanock, Stephen J
Chines, Peter S
Chung, Mina
Darbar, Dawood
Dina, Christian
Dörr, Marcus
Elliott, Paul
Felix, Stephan B
Fischer, Krista
Fuchsberger, Christian
de Geus, Eco J C
Goyette, Philippe
Gudnason, Vilmundur
Harris, Tamara B
Hartikainen, Anna-Liisa
Havulinna, Aki S
Heckbert, Susan R
Hicks, Andrew A
Hofman, Albert
Holewijn, Suzanne
Hoogstra-Berends, Femke
Hottenga, Jouke-Jan
Jensen, Majken K
Johansson, Asa
Junttila, Juhani
Kääb, Stefan
Kanon, Bart
Ketkar, Shamika
Khaw, Kay-Tee
Knowles, Joshua W
Kooner, Angrad S
Kors, Jan A
Kumari, Meena
Milani, Lili
Laiho, Päivi
Lakatta, Edward G
Langenberg, Claudia
Leusink, Maarten
Liu, Yongmei
Luben, Robert N
Lunetta, Kathryn L
Lynch, Stacey N
Markus, Marcello R P
Marques-Vidal, Pedro
Mateo Leach, Irene
McArdle, Wendy L
McCarroll, Steven A
Medland, Sarah E
Miller, Kathryn A
Montgomery, Grant W
Morrison, Alanna C
Müller-Nurasyid, Martina
Navarro, Pau
Nelis, Mari
O'Connell, Jeffrey R
O'Donnell, Christopher J
Ong, Ken K
Newman, Anne B
Peters, Annette
Polasek, Ozren
Pouta, Anneli
Pramstaller, Peter P
Psaty, Bruce M
Rao, Dabeeru C
Ring, Susan M
Rossin, Elizabeth J
Rudan, Diana
Sanna, Serena
Scott, Robert A
Sehmi, Jaban S
Sharp, Stephen
Shin, Jordan T
Singleton, Andrew B
Smith, Albert V
Soranzo, Nicole
Spector, Tim D
Stewart, Chip
Stringham, Heather M
Tarasov, Kirill V
Uitterlinden, André G
Vandenput, Liesbeth
Hwang, Shih-Jen
Whitfield, John B
Wijmenga, Cisca
Wild, Sarah H
Willemsen, Gonneke
Wilson, James F
Witteman, Jacqueline C M
Wong, Andrew
Wong, Quenna
Jamshidi, Yalda
Zitting, Paavo
Boer, Jolanda M A
Boomsma, Dorret I
Borecki, Ingrid B
van Duijn, Cornelia M
Ekelund, Ulf
Forouhi, Nita G
Froguel, Philippe
Hingorani, Aroon
Ingelsson, Erik
Kivimaki, Mika
Kronmal, Richard A
Kuh, Diana
Lind, Lars
Martin, Nicholas G
Oostra, Ben A
Pedersen, Nancy L
Quertermous, Thomas
Rotter, Jerome I
van der Schouw, Yvonne T
Verschuren, W M Monique
Walker, Mark
Albanes, Demetrius
Arnar, David O
Assimes, Themistocles L
Bandinelli, Stefania
Boehnke, Michael
de Boer, Rudolf A
Bouchard, Claude
Caulfield, W L Mark
Chambers, John C
Curhan, Gary
Cusi, Daniele
Eriksson, Johan
Ferrucci, Luigi
van Gilst, Wiek H
Glorioso, Nicola
de Graaf, Jacqueline
Groop, Leif
Gyllensten, Ulf
Hsueh, Wen-Chi
Hu, Frank B
Huikuri, Heikki V
Hunter, David J
Iribarren, Carlos
Isomaa, Bo
Jarvelin, Marjo-Riitta
Jula, Antti
Kähönen, Mika
Kiemeney, Lambertus A
van der Klauw, Melanie M
Kooner, Jaspal S
Kraft, Peter
Iacoviello, Licia
Lehtimäki, Terho
Lokki, Marja-Liisa L
Mitchell, Braxton D
Navis, Gerjan
Nieminen, Markku S
Ohlsson, Claes
Poulter, Neil R
Qi, Lu
Raitakari, Olli T
Rimm, Eric B
Rioux, John D
Rizzi, Federica
Rudan, Igor
Salomaa, Veikko
Sever, Peter S
Shields, Denis C
Shuldiner, Alan R
Sinisalo, Juha
Stanton, Alice V
Stolk, Ronald P
Strachan, David P
Tardif, Jean-Claude
Thorsteinsdottir, Unnur
Tuomilehto, Jaako
van Veldhuisen, Dirk J
Virtamo, Jarmo
Viikari, Jorma
Vollenweider, Peter
Waeber, Gérard
Widen, Elisabeth
Cho, Yoon Shin
Olsen, Jesper V
Visscher, Peter M
Willer, Cristen
Franke, Lude
Erdmann, Jeanette
Thompson, John R
Pfeufer, Arne
Sotoodehnia, Nona
Newton-Cheh, Christopher
Ellinor, Patrick T
Stricker, Bruno H Ch
Metspalu, Andres
Perola, Markus
Beckmann, Jacques S
Smith, George Davey
Stefansson, Kari
Wareham, Nicholas J
Munroe, Patricia B
Sibon, Ody C M
Milan, David J
Snieder, Harold
Samani, Nilesh J
Loos, Ruth J F
Issue Date
2013-06
Metadata
Show full item recordCitation
Nat. Genet. 2013, 45 (6):621-31Abstract
Elevated resting heart rate is associated with greater risk of cardiovascular disease and mortality. In a 2-stage meta-analysis of genome-wide association studies in up to 181,171 individuals, we identified 14 new loci associated with heart rate and confirmed associations with all 7 previously established loci. Experimental downregulation of gene expression in Drosophila melanogaster and Danio rerio identified 20 genes at 11 loci that are relevant for heart rate regulation and highlight a role for genes involved in signal transmission, embryonic cardiac development and the pathophysiology of dilated cardiomyopathy, congenital heart failure and/or sudden cardiac death. In addition, genetic susceptibility to increased heart rate is associated with altered cardiac conduction and reduced risk of sick sinus syndrome, and both heart rate-increasing and heart rate-decreasing variants associate with risk of atrial fibrillation. Our findings provide fresh insights into the mechanisms regulating heart rate and identify new therapeutic targets.Description
To access publisher's full text version of this article click on the hyperlink at the bottom of the pageAdditional Links
http://dx.doi.org/10.1038/ng.2610http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3696959/
http://www.nature.com/ng/journal/v45/n6/pdf/ng.2610.pdf
Rights
Archived with thanks to Nature geneticsae974a485f413a2113503eed53cd6c53
10.1038/ng.2610
Scopus Count
Collections
Related articles
- Genome- and phenome-wide analyses of cardiac conduction identifies markers of arrhythmia risk.
- Authors: Ritchie MD, Denny JC, Zuvich RL, Crawford DC, Schildcrout JS, Bastarache L, Ramirez AH, Mosley JD, Pulley JM, Basford MA, Bradford Y, Rasmussen LV, Pathak J, Chute CG, Kullo IJ, McCarty CA, Chisholm RL, Kho AN, Carlson CS, Larson EB, Jarvik GP, Sotoodehnia N, Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) QRS Group., Manolio TA, Li R, Masys DR, Haines JL, Roden DM
- Issue date: 2013 Apr 2
- Dissection of a quantitative trait locus for PR interval duration identifies Tnni3k as a novel modulator of cardiac conduction.
- Authors: Lodder EM, Scicluna BP, Milano A, Sun AY, Tang H, Remme CA, Moerland PD, Tanck MW, Pitt GS, Marchuk DA, Bezzina CR
- Issue date: 2012
- Quantitative trait loci for electrocardiographic parameters and arrhythmia in the mouse.
- Authors: Scicluna BP, Tanck MW, Remme CA, Beekman L, Coronel R, Wilde AA, Bezzina CR
- Issue date: 2011 Mar
- Several common variants modulate heart rate, PR interval and QRS duration.
- Authors: Holm H, Gudbjartsson DF, Arnar DO, Thorleifsson G, Thorgeirsson G, Stefansdottir H, Gudjonsson SA, Jonasdottir A, Mathiesen EB, Njølstad I, Nyrnes A, Wilsgaard T, Hald EM, Hveem K, Stoltenberg C, Løchen ML, Kong A, Thorsteinsdottir U, Stefansson K
- Issue date: 2010 Feb
- Variant Intronic Enhancer Controls <i>SCN10A-short</i> Expression and Heart Conduction.
- Authors: Man JCK, Bosada FM, Scholman KT, Offerhaus JA, Walsh R, van Duijvenboden K, van Eif VWW, Bezzina CR, Verkerk AO, Boukens BJ, Barnett P, Christoffels VM
- Issue date: 2021 Jul 20
Related items
Showing items related by title, author, creator and subject.
-
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals.Dastani, Zari; Hivert, Marie-France; Timpson, Nicholas; Perry, John R B; Yuan, Xin; Scott, Robert A; Henneman, Peter; Heid, Iris M; Kizer, Jorge R; Lyytikäinen, Leo-Pekka; et al. (2012)Circulating levels of adiponectin, a hormone produced predominantly by adipocytes, are highly heritable and are inversely associated with type 2 diabetes mellitus (T2D) and other metabolic traits. We conducted a meta-analysis of genome-wide association studies in 39,883 individuals of European ancestry to identify genes associated with metabolic disease. We identified 8 novel loci associated with adiponectin levels and confirmed 2 previously reported loci (P = 4.5×10(-8)-1.2×10(-43)). Using a novel method to combine data across ethnicities (N = 4,232 African Americans, N = 1,776 Asians, and N = 29,347 Europeans), we identified two additional novel loci. Expression analyses of 436 human adipocyte samples revealed that mRNA levels of 18 genes at candidate regions were associated with adiponectin concentrations after accounting for multiple testing (p<3×10(-4)). We next developed a multi-SNP genotypic risk score to test the association of adiponectin decreasing risk alleles on metabolic traits and diseases using consortia-level meta-analytic data. This risk score was associated with increased risk of T2D (p = 4.3×10(-3), n = 22,044), increased triglycerides (p = 2.6×10(-14), n = 93,440), increased waist-to-hip ratio (p = 1.8×10(-5), n = 77,167), increased glucose two hours post oral glucose tolerance testing (p = 4.4×10(-3), n = 15,234), increased fasting insulin (p = 0.015, n = 48,238), but with lower in HDL-cholesterol concentrations (p = 4.5×10(-13), n = 96,748) and decreased BMI (p = 1.4×10(-4), n = 121,335). These findings identify novel genetic determinants of adiponectin levels, which, taken together, influence risk of T2D and markers of insulin resistance.
-
A genome-wide association search for type 2 diabetes genes in African Americans.Palmer, Nicholette D; McDonough, Caitrin W; Hicks, Pamela J; Roh, Bong H; Wing, Maria R; An, S Sandy; Hester, Jessica M; Cooke, Jessica N; Bostrom, Meredith A; Rudock, Megan E; et al. (2012)African Americans are disproportionately affected by type 2 diabetes (T2DM) yet few studies have examined T2DM using genome-wide association approaches in this ethnicity. The aim of this study was to identify genes associated with T2DM in the African American population. We performed a Genome Wide Association Study (GWAS) using the Affymetrix 6.0 array in 965 African-American cases with T2DM and end-stage renal disease (T2DM-ESRD) and 1029 population-based controls. The most significant SNPs (n = 550 independent loci) were genotyped in a replication cohort and 122 SNPs (n = 98 independent loci) were further tested through genotyping three additional validation cohorts followed by meta-analysis in all five cohorts totaling 3,132 cases and 3,317 controls. Twelve SNPs had evidence of association in the GWAS (P<0.0071), were directionally consistent in the Replication cohort and were associated with T2DM in subjects without nephropathy (P<0.05). Meta-analysis in all cases and controls revealed a single SNP reaching genome-wide significance (P<2.5×10(-8)). SNP rs7560163 (P = 7.0×10(-9), OR (95% CI) = 0.75 (0.67-0.84)) is located intergenically between RND3 and RBM43. Four additional loci (rs7542900, rs4659485, rs2722769 and rs7107217) were associated with T2DM (P<0.05) and reached more nominal levels of significance (P<2.5×10(-5)) in the overall analysis and may represent novel loci that contribute to T2DM. We have identified novel T2DM-susceptibility variants in the African-American population. Notably, T2DM risk was associated with the major allele and implies an interesting genetic architecture in this population. These results suggest that multiple loci underlie T2DM susceptibility in the African-American population and that these loci are distinct from those identified in other ethnic populations.
-
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes riskDupuis, Josée; Langenberg, Claudia; Prokopenko, Inga; Saxena, Richa; Soranzo, Nicole; Jackson, Anne U; Wheeler, Eleanor; Glazer, Nicole L; Bouatia-Naji, Nabila; Gloyn, Anna L; et al. (Nature Pub. Co, 2010-02-01)Levels of circulating glucose are tightly regulated. To identify new loci influencing glycemic traits, we performed meta-analyses of 21 genome-wide association studies informative for fasting glucose, fasting insulin and indices of beta-cell function (HOMA-B) and insulin resistance (HOMA-IR) in up to 46,186 nondiabetic participants. Follow-up of 25 loci in up to 76,558 additional subjects identified 16 loci associated with fasting glucose and HOMA-B and two loci associated with fasting insulin and HOMA-IR. These include nine loci newly associated with fasting glucose (in or near ADCY5, MADD, ADRA2A, CRY2, FADS1, GLIS3, SLC2A2, PROX1 and C2CD4B) and one influencing fasting insulin and HOMA-IR (near IGF1). We also demonstrated association of ADCY5, PROX1, GCK, GCKR and DGKB-TMEM195 with type 2 diabetes. Within these loci, likely biological candidate genes influence signal transduction, cell proliferation, development, glucose-sensing and circadian regulation. Our results demonstrate that genetic studies of glycemic traits can identify type 2 diabetes risk loci, as well as loci containing gene variants that are associated with a modest elevation in glucose levels but are not associated with overt diabetes.